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Abbreviations 
 A-unit of CS, GlcAβ1-3GalNAc(4-O-sulfate); C-unit of CS, GlcAβ1-3GalNAc(6-O-sulfate); 
BSA, bovine serum albumin; CS, chondroitin sulfate; CS-PE, lipid-derivatized chondroitin 
sulfate; CS-PE beads, polystyrene beads coated with lipid-derivatized chondroitin sulfate; 
CSPG, chondroitin sulfate proteoglycan; D-unit of CS, GlcA(2-O-sulfate)β1-3GalNAc(6-O-
sulfate); E-unit of CS, GlcAβ1-3GalNAc(4,6-O-disulfate); GalNAc, N-acetylgalactosamine; 
GlcA, glucuronic acid; PBS, phosphate-buffered saline; PE, phosphatidylethanolamine; PTP, 
protein tyrosine phosphatase 
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Abstract 
Chondroitin sulfate (CS), the carbohydrate chain of chondroitin sulfate proteoglycans, is 
involved in neuronal circuit formation during development.  CS shows great structural 
diversity with combination of disaccharide units of different structure (A-, C-, D-, or E-
unit).  However, whether its structural diversity contributes to pathway formation 
remains unclear.  We chemically coupled the reducing end of various types of CS to 
the amino group of phosphatidylethanolamine (lipid-derivatized CS, CS-PE) and 
established an in vitro time-lapse assay to observe the behaviors of growth cones of 
retinal ganglion cells from embryonic day 6 chick retina on exposure to beads coated 
with lipid-derivatized CS (CS-PE beads).  Among CS-PEs with different content of the 
structural units, the beads coated with E-unit–containing CS-PE [E-unit: GlcAβ1-
3GalNAc(4,6-O-disulfate)] (CSE-PE beads) significantly caused the growth cones to 
retract and to turn away from the beads, but the beads coated with CSA-, CSC- or CSD-
PE beads did not.  Importantly, not all the growth cones retracted equally from the 
CSE-PE beads, but they showed continuum of the repulsive behaviors; some behaved 
moderately and others remarkably.  The growth cones distinguished different samples 
of CS: CSE and the others.  Moreover, the continuum of the repulsive behaviors 
suggests that CS might be involved with the fine regulation of growth cones' behavior 
through its characteristic structure.    
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1. Introduction 
Neurons extend their axons along a precise pathway with the help of guidance cues 
and receptors during development.  Chondroitin sulfate proteoglycans (CSPGs) act as guid-
ance cues or modulators that inhibit axonal growth at various decision points along the neu-
ronal pathway (Ichijo, 2004; Holt and Dickson, 2005; Carulli et al., 2005).  CSPG comprises 
a core protein and carbohydrate chains of CS.  CS is an unbranched polymer comprising 
repeating disaccharide units of glucuronic acid (GlcA) and N-acetylgalactosamine (GalNAc).   
The inhibitory effects of CS have been shown in the axonal outgrowth of retinal 
ganglion cells in vitro, pathway formation of retinal axons in vivo, glial roof plate, and axonal 
pathways in the spinal cord (Snow et al., 1990; Snow et al., 1991; Brittis et al., 1992; Brittis et 
al., 1994; Hoffman-Kim et al., 1998; Chung et al., 2000; Yick et al., 2000; Ichijo and Kawa-
bata, 2001; Moon et al., 2001; Becker and Becker, 2002; Walz et al., 2002; Masuda et al., 
2004).  Because the inhibitory effect of CS is an important factor that prevents spinal axons 
from regenerating in the central nervous system after injury, researches have focused on the 
therapeutic utility of CS removal from glial scars (Bradbury et al., 2002; Morgenstern et al., 
2002; Busch and Silver, 2007; Cafferty et al., 2008).  Further, CS exhibits various effects on 
different neurons.  CS promotes neurite outgrowth in vitro (Faissner et al., 1994; Fernaud-
Espinosa et al., 1994; Challacombe and Elam, 1997; Clement et al., 1998; Nadanaka et al., 
1998; Clement et al. 1999) and functions as a target-derived neurotrophic factor for retinal 
ganglion cells in rat (Huxlin et al., 1993).  Effects of CS on circuit plasticity in the visual cor-
tex have also been studied (Lander et al., 1997; Pizzorusso et al., 2002; Pizzorusso et al., 
2006; Carulli et al., 2010).   
It is well known that CS exhibits structural diversity.  The disaccharide unit of CS 
(GlcA-GalNAc) is modified by sulfation at different positions, resulting in different structures 
of the units classified as O-unit (GlcA-GalNAc), A-unit (GlcA-GalNAc4S), C-unit (GlcA-
GalNAc6S), D-unit (GlcA2S-GalNAc6S), and E-unit (GlcA-GalNAc4S6S) (Fig. 1).  These 
 6 
units combine, resulting in structural diversity.  Structurally diverse CSs have different ef-
fects during neurite elongation (Wang et al., 2008; Lin et al., 2011) and cortical layer for-
mation (Ishii and Maeda, 2008; Nishimura et al., 2010).  E-unit containing CS promotes neu-
rite outgrowth of hippocampal neurons in vitro (Clement et al. 1999), suggesting the differen-
tial effects between neuronal cell types.  However, it remains unknown how the different 
structures of CSs exert diverse effects on different neuronal cells in different contexts through 
specific cellular responses.  Recent findings suggest that cells might recognize the specific 
structure of CS (Clement et al., 1998; Nadanaka et al., 1998; Oohira et al., 2000; Ueoka et al., 
2000; Gilbert et al., 2005; Properzi et al., 2005).  Proteins binding to CS specifically recog-
nize octa- or decasaccharides of CS chains with particular sequences but not non-specific 
characters such as their full lengths or net charges (Blanchard et al., 2007; Deepa et al., 
2007a; Deepa et al., 2007b; Pothacharoen et al., 2007; Numakura et al., 2010).  Thus, it is 
proposed that cells recognize CS through cell surface receptors such as transmembrane pro-
tein tyrosine phosphatase (PTPσ) and contactin-1, which have been shown to be involved in 
the receiving of the effects of CS (Mikami et al., 2009; Shen et al., 2009; Coles et al., 2011).   
Among the many neuronal circuits, the retinotectal pathway is most amenable to 
experimental approaches.  In the chick optic tract, axons of retinal ganglion cells are demar-
cated by CS labeled with MO-225 anti-CS monoclonal antibody; MO-225 epitopes are dis-
tributed on the diencephalotelencephalic boundary and in the neuropils encircling the optic 
tract (Ichijo, 2006).  This observation suggests that the structural diversity of CS plays a role 
in CSPG-mediated ax-on guidance; however, the effect of CS structural diversity on retinal 
growth cones has not been investigated in detail.  In this study, we chemically coupled the 
reducing end of various types of CS to the amino group of phosphatidylethanolamine (lipid-
derivatized CS, CS-PE) (Sugiura et al., 1993; Oohira et al., 2000) and immobilized the CS-
PE hydrophobically on polystyrene beads.  We established an in vitro time-lapse assay to 
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observe the chick retinal growth cones that en-countered the CS-PE beads and examined 
the effects of CS structural diversity on growth cone behavior.  The retinal growth cones 
moved away selectively from the CSE-PE beads, indicating that the growth cones distinguish 
CSE from the others and differentiate their structure.  Importantly, not all the growth cones 
retracted equally from the CSE-PE beads, but they showed continuum of the repulsive be-
haviors, which suggests that CS might be involved with the fine regulation of growth cones' 
behavior through its characteristic structure.   
 
2. Results 
2.1. Structural diversity of CS examined using beads coated with lipid-derivatized CS 
Four kinds of CS-PE beads were prepared: CSA-, CSC-, CSD-, and CSE-PE beads.  Immunore-
activity of the CS-PE beads was examined using various anti-CS monoclonal antibodies of differ-
ent specificities.  To demonstrate the configuration of CS-PE and polystyrene beads, CSD-PE 
beads were treated with enzymes, followed by CS-56 immunostaining and flow cytometry (Fig. 
2B).  The signal intensity of CSD-PE beads disappeared completely after phospholipase D 
treatment.  Because phospholipase D cleaves phosphatidylethanolamine and releases the CS 
portion from the beads, the result shows that the PE portion of the CS-PE molecules is immobi-
lized on the beads by hydrophobic interaction.  Furthermore, treatment with chondroitinase ABC 
caused variable reductions in CS immunoreactivity, seen as a broader peak (Fig. 2B), which indi-
cates that CS carbohydrate chains are situated outside the PE portion and envelop the beads.   
The beads coated with CSA-PE, CSC-PE, CSD-PE, and CSE-PE were differentially 
recognized using the following anti-CS antibodies: MO-225, CS-56, and 2H6 (Fig. 2C).  The 
MO-225 anti-CS antibody preferentially binds to the C-, D-, and E-units of CS; the signals with 
MO-225 were intense on the CSC-PE, CSD-PE, and CSE-PE beads but only weak on the 
CSA-PE beads.  The MO-225 anti-CS monoclonal antibody was originally reported to bind to 
D-unit-rich CS (Yamagata et al., 1987).  It was later reported that MO225 recognizes group of 
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6 - 10 saccharides, sequences of the units like C-A-D-C, A-D-C, A-D-A, and E-E-E-E-C (Ito et 
al., 2005; Deepa et al., 2007ab).  Thus, MO-225 is likely to recognize groups of the units in-
cluding the E-unit but do not exclusively E-unit proper (Fig 2C).   
The CS-56 anti-CS antibody preferentially binds to the C- and D-units; the signals 
with CS-56 were intense on the CSC-PE and CSD-PE beads but weak on the CSA-PE and 
CSE-PE beads (Fig 2C).  The 2H6 anti-CS antibody preferentially binds to the A-units; the 
signals with 2H6 were intense on the CSA-PE beads but weak on the CSC-PE, CSD-PE, and 
CSE-PE beads (Fig 2C).  These binding preferences confirmed the specificity of anti-CS anti-
bodies.  These results showed that the different structural diversity of CSA-PE, CSC-PE, 
CSD-PE, and CSE-PE was represented on the beads, which confirms that retinal growth cones 
were exposed to particular structures of CS when they encountered each bead.   
 
2.2. Differential behaviors of retinal growth cones toward beads coated with lipid-
derivatized CS 
On the culture substrate, most of the beads stood still and some moved unsteadily.  To ex-
clude non-specific influences of the unsteady beads, for example, a mechanical impact, we ex-
amined only the beads standing still in the analyses.  Retinal growth cones showed diverse 
behaviors when they encountered the beads but did not show stereotypical behavior against 
specific beads.  The behaviors were approximately classified into 3 types: retraction, turn, and 
no change (Figs. 3, and supplemental movies).  Since random nature of the growth cone re-
sponses was concerned, we firstly examined correlation between growth cones' behaviors and 
touching angles of growth cones to a bead coated with crude CS-PE.  "Turn" reflected approx-
imate turning angle more than 15° as shown in the experimental procedures.  In the scatter 
plot (Fig. 2D), no correlation was observed between the touching angles and behaviors; thus, 
different trajectories of growth cone migration relative to a bead were not thought to result in 
the three types of behaviors.   
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Retinal growth cones encountering CSE-PE beads showed higher percentages of re-
traction (CSE-PE beads: 9.7%, n = 93) (Figs. 4A).  Those encountering CSC-PE or CSD-PE 
beads showed moderate percentages of retraction (CSC-PE beads: 6.6%, n = 76; CSD-PE 
beads: 5.1%, n = 78), and those encountering raw beads or CSA-PE beads showed lower per-
centages of retraction (raw beads: 2.4%, n = 85; CSA-PE beads: 0%, n = 83).  Treatment with 
chondroitinase ABC quenched the effect of CSE-PE beads on retraction (CSE-PE beads treat-
ed with chondroitinase ABC: 2.2%, n = 93).  The percentage of growth cones’ retraction was 
significantly greater with CSE-PE beads than with raw beads (by chi-square test, p < 0.05), 
CSA-PE beads (p < 0.01) and CSE-PE beads treated with chondroitinase ABC (p < 0.05).  
The percentage of retraction induced by CSC-PE or CSD-PE beads was not significantly dif-
ferent from that induced by raw beads.   
Moreover, the growth cones retracted significantly more slowly on CSE-PE beads 
than the other beads (mean ± standard deviation: CSE-PE, 35.3 ± 17.8 min, n = 9) (non CSE-
PE, 9.8 ± 5.9 min, n = 13) (Mann-Whitney U test, p < 0.01) (Supplemental movies and Figs. 
4B).  This was also the case except for the retraction.  We determined how long the growth 
cone halted after contacting the bead.  In the scatter plots, a fraction of the growth cones halt-
ed for longer on encountering CSE-PE beads than the others, although individual growth cones 
halted for various periods (Fig. 5A).  The mean halt time of the growth cones was significantly 
longer on the CSE-PE beads than the others (CSE-PE bead: 10.9 ± 11.0 min, raw bead: 8.7 ± 
4.1 min, CSA-PE bead: 7.7 ± 4.9 min, CSC-PE bead: 9.7 ± 5.2 min, CSD-PE bead: 8.6 ± 5.5 
min) and the CSE-PE beads treated with chondroitinase ABC (9.1 ± 4.9 min) [ANOVA followed 
by Bonferroni's multiple comparison test: the CSE-PE bead against raw beads (p < 0.05), CSA-
PE beads (p < 0.01), and CSD-PE bead (p < 0.05)] (Fig. 5B).   
Except for retraction and halt, the growth cones altered their growth direction on en-
countering the beads, although some passed by the beads without changing their direction.  In 
particular, growth cones encountering the CSE-PE beads turned away from the beads with a 
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large angle (Fig. 3C).  To elucidate growth cone turning, the angles of growth direction change 
were measured and plotted (Fig. 5C).  An angle above zero indicates that the growth cones 
moved away from the beads, and an angle below zero indicates that they moved toward the 
beads.  Growth cones turned significantly away from CSE-PE beads (12.4° ± 19.9°).  Small 
angles of deflection were observed for raw beads (1.1° ± 9.9°) and beads coated with CSA-PE 
(1.8° ± 12.1°), CSC-PE (4.0° ± 15.9°) or CSD-PE (3.0° ± 11.6°).  The effect of CSE-PE beads 
on the turning angle was quenched by treatment with chondroitinase ABC (2.7° ± 11.9°).  The 
turning angles for CSE-PE beads were significantly different from those for all other types of 
beads (ANOVA followed by Bonferroni's multiple comparison test, p < 0.01) (Fig. 5D).   
Since the growth cones turning angles against CSE-PE bead seemed to be distribut-
ed in a bimodal manner at 20° (Fig. 5C) and the turning angle more than 20° were easily rec-
ognized in time-lapse movie at a glance, behaviors of growth cones were categorized into 3 
types as retraction (A), turning away by more than 20° (B) and turning by less than 20° (C).  
The percentages shown (A+B)/(A+B+C) as "growth cones moving away remarkably" were 
evaluated using the chi-square test (Fig. 6).  Retinal growth cones encountering CSE-PE 
beads showed higher percentage of the remarkable response (CSE-PE beads: 41.9%, n = 93).  
Those encountering CSC-PE beads showed moderate percentage (CSC-PE beads: 15.8%, n = 
76), and those encountering raw beads, CSA-PE beads, or CS-D beads showed lower per-
centages (raw beads: 5.9%, n = 85; CSA-PE beads: 6.0%, n = 83; CSDE-PE beads: 9.0%, n = 
78).  Treatment with chondroitinase ABC quenched the effect of CSE-PE beads (CSE-PE 
beads treated with chondroitinase ABC: 10.8%, n = 93).  The percentage of growth cones with 
the remarkable behaviors was significantly greater on the CSE-PE bead than on the others (by 
chi-square test, p < 0.0001).   
 
3. Discussion 
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Four kinds of CS-PE beads were prepared: CSA-, CSC-, CSD-, and CSE-PE beads.  Axonal 
growth cones probe CS-PE beads, which enables us to question whether growth cones sense 
and behave differently according to the structural diversity of CS.  Thus, CS-PE beads are a fea-
sible substrate for investigating the structural diversity of CS and its function.  The present meth-
od allows us to specify when and where the CS affects individual growth cones in the time-lapse 
movies, which further opens the possibility to investigate the intracellular mechanism with high 
spatiotemporal resolution.  Coating the CS-PE beads with BSA inhibited non-specific binding (da-
ta not shown); however, it is theoretically possible that unknown factors conditioned by retinal 
cells may bind only to specific types of CS and exert their influences on growth cone behavior as 
suggested in previous investigations (Ishii and Maeda, 2008; Wang et al., 2008; Mikami et al., 
2009; Nishimura et al., 2010; Lin et al., 2011).   
 The inhibitory effects of CS have been shown on the axonal outgrowth of retinal ganglion 
cells in vitro (Ichijo and Kawabata, 2001; Lam et al., 2008) and pathway formation of retinal axons 
in vivo (Chung et al., 2000; Ichijo and Kawabata, 2001; Walz et al., 2002), indicating that CS de-
limits the border of the axonal pathway and prevents the axons from entering aberrant territory.  
Especially, CS recognized by MO-225 has been a structural candidate because its epitopes are 
distributed on the diencephalotelencephalic boundary, in the neuropil encircling the optic tract 
(Ichijo, 2006), and in the telencephalon (Ichijo, 2007).  Here, we showed that CSE-PE beads 
recognized by MO-225 caused repulsion during retinal growth cone steering.  The CSE-PE 
beads halted the growth cones for a longer period and induced the growth cone’s retraction more 
frequently than the others (Figs. 3, 4, and 5).  The CSE-PE beads caused the growth cones to 
turn away from the beads (Fig. 5).  The CSE-PE beads induced significantly higher percentages 
of the remarkable repulsive behaviors (the retracted growth cones or growth cones turning angle 
more than 20°) than the others (Fig. 6).  The results suggest that E-unit-containing CS might pre-
vents retinal axons from invading aberrant territory and delimits the border of retinal trajectory by 
encircling the optic tract.   
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 However, the effects of CSE-PE beads seem to differ from those of the well-known pro-
teinaceous repulsive cues: semaphorins and ephrins (Fournier et al., 2000; Weinl et al., 2003).  
CSE-PE beads did not induce drastic effects on all axons but rather moderately regulated axonal 
behavior.  Importantly, not all the growth cones equally retracted from, halted on, or turned from 
the CSE-PE beads, but they showed continuum of the repulsive behaviors (Fig. 5A and C); some 
behaved moderately and others remarkably.  It is unknown how retinal growth cones behave dif-
ferentially toward CSE-PE beads; however, there are two possibilities.  The first is that retinal 
growth cones discriminate heterogeneity within the CSE chain on the beads.  In flow cytometric 
analysis, CSE-PE beads showed broad peaks of immunoreactivity against CS-56 and 2H6, de-
spite its sharp peak against MO-225 (Fig 2C).  The broad peaks of immunoreactivity result from 
the heterogeneity within the CSE chains.  In CSE chains with higher percentages of E-units, oth-
er units were combined and aligned (Table 1), which is responsible for the heterogeneity within 
the CSE; for example, differences in the sequence or clustering of disaccharide units.  It is con-
ceivable that the structural heterogeneity within the CS chain is biologically relevant to the fine 
regulation of CS function, because each CS was prepared from biological samples.  The second 
possibility is that retinal growth cones vary their sensitivity to E-unit-containing CS.  Neurite out-
growth of hippocampal neurons is promoted on E-unit containing CS in vitro (Clement et al. 1999), 
suggesting that differential effects between neuronal cell types.  Transmembrane protein tyrosine 
phosphatase (PTPσ) and contactin-1 were shown to be the functional receptors of CSPG and 
CSE, respectively (Mikami et al., 2009; Shen et al., 2009; Coles et al., 2011); it would be intriguing 
if this is the case in pathway formation of retinal axons.  It has been reported in vitro, using CS-
biotin-streptavidin complex, that some retinal axons growing on CS-containing substrate reduce 
the MO-225 staining along axons (Ando 2010), which is thought to be an adaptation for the retinal 
axons to alter their microenvironment for growth.  Alteration of the CS microenvironment may re-
duce sensitivity to CSE-PE beads and lead to diverse behaviors.   
 13 
 In vivo, the chronological order of retinal axon growth is well studied in the optic tract.  
The late-growing retinal axons run through the superficial layer of the optic tract, whereas the ear-
ly-growing axons run through the deep layer of the optic tract in contact with MO-225-positive neu-
ropil (Rager, 1980; Leung et al., 2003; Ichijo, 2006), which suggests that the axons in the deep 
layer run on the neuropil with MO-225-positive CS.  The differential repulsive effect of CS con-
taining E-units might be involved with the chronological sorting.  Role of CS in activity-dependent 
fine-tuning have also been shown in ocular dominance plasticity in the visual cortex (Pizzorusso et 
al., 2002; Pizzorusso et al., 2006; Carulli et al., 2010); it would be intriguing to determine whether 
the structural diversity of CS is involved in this process, as well.   
 It is important but difficult to investigate relationship between structural diversity of CS and 
its functional specificity.  Here we showed the effects of biological sample of E-unit-containing CS 
(CSE from squid).  We used commercially available samples of CS; thus, mean molecular 
weights of CS-PEs were not exactly the same (Table 1).  Since recent findings suggest that cells 
might recognize a specific structure of CS (Blanchard et l., 2007; Clement et al., 1998; Deepa et 
al., 2007a; Deepa et al., 2007b; Nadanaka et al., 1998; Numakura et al., 2010; Oohira et al., 
2000; Ueoka et al., 2000; Gilbert et al., 2005; Properzi et al., 2005; Pothacharoen et al., 2007), 
different lengths of CS chain are not thought to result in their effects; however, to use better prep-
arations of CS with similar lengths would be considered in further investigations.   
 There is no assurance that the same structure in the CSE used in the experiments exists 
and functions in vivo, but the results indicate that the growth cones differentiate CS with various 
unit contents, suggesting that the growth cones might sense different structure of CS.  It must be 
further investigated how detailed structure of CS is and how its structure is involved with regula-
tion of the growth cones' behaviors.  Synthesized CS oligosaccharides with defined sequences 
would be ideal for this purpose.   
 
4. Experimental Procedure 
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4.1. Formation of polystyrene beads coated with lipid-derivatized CS  
CS preparations: CS, CSA, CSC, CSD, and CSE were purchased from Seikagaku (Tokyo, Ja-
pan).  The disaccharide unit composition of each CS was analyzed with fluorometric post-
column high-performance liquid chromatography (Table 1).  Since we used commercially 
available samples of CS and their coupling efficiency to PE was low, mean molecular weights 
of CS-PEs were not exactly the same.  Partial digestion of CS chains was not performed be-
cause recent findings showed that cells or binding proteins recognize the structural motifs of 
octa- or decasaccharides but do not recognize whole length of CS chain.  We did the experi-
ments based on these facts.  The reducing ends of CS were chemically coupled to the amino 
group of phosphatidylethanolamine (PE) to obtain lipid-derivatized CS (CS-PE) (Fig. 2A) 
(Sugiura et al., 1993).  Polystyrene beads (5–6 µm in diameter; Spherotech Inc., Lake Forest, 
IL) were incubated overnight at 37.5 °C in CS-PE solution (200 µg/ml CS-PE in PBS).  Once 
the beads were coated with CS-PE (CS-PE beads), they were treated with bovine serum albu-
min (BSA) to block nonspecific binding.    
Immunoreactivity of the CS-PE beads was examined using anti-CS monoclonal anti-
bodies of different specificities.  CS-PE beads were washed in PBS and treated with 3.7% 
formaldehyde in PBS at room temperature for 2 h.  They were washed twice in PBS, treated 
with 10% normal goat serum (Invitrogen, Carlsbad, CA) and incubated with anti-CS monoclonal 
antibody.  Monoclonal antibodies against CS (2H6, MC21C, and MO-225) (Yamagata et al., 
1987; Mark et al., 1989; Maeda et al., 1992; Oohira et al., 1994) were purchased from 
Seikagaku.  CS-56 monoclonal antibody (Avnur and Geiger, 1984) was purchased from Sig-
ma (St. Louis, MO).  After the treatment with anti-CS antibodies, CS-PE beads were washed 3 
times in PBS.  Subsequently, they were incubated with goat anti-mouse IgG antibody conju-
gated with Alexa Fluor 488 (Invitrogen) as the secondary antibody.  At some instances, before 
immunostaining, the CS-PE beads were treated overnight at 37 °C with phospholipase D (25 U, 
BIOMOL International, Plymouth Meeting, PA) or chondroitinase ABC (50 mU, Seikagaku) with 
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gentle agitation.  The immunostained CS-PE beads were analyzed using a flow cytometer 
(Becton Dickinson, Franklin Lakes, NJ) and relevant software (FlowJo, Ashland, OR).   
 
4.2. Retinal explant culture and time-lapse recording 
Fertilized chicken eggs were obtained from a local farm.  They were incubated at 37 °C.  Ret-
inal explants were prepared from embryonic day 6 chicks as described previously (Ichijo and 
Kawabata, 2001) and cultured at 37.5 °C on a substrate coated with poly-D-lysine (10 µg/ml, 
Sigma) and laminin (40 µg/ml, Invitrogen) in a serum-free chemically defined medium: 25 mM 
HEPES (4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid)-buffered F12 nutrient mixture with 
N2 supplement (Invitrogen).  The CS-PE beads were scattered on the culture substrate 
around the explant at a density of 150–200 particles/cm2.  A phase contrast inverted micro-
scope (TE-2000E, Nikon, Tokyo, Japan) was used to observe the retinal axon growth cones, 
which grew out of the explant and encountered the beads.  The time-lapse images of retinal 
growth cones were recorded using a digital camera and its controlling software (D50 and NIS-
Elements, Nikon).  To quantify growth cone retraction, the percentages of retracted growth 
cones and mean halt time of the retraction were evaluated using the chi-square test and Mann-
Whitney U test, respectively.  Halt time of the growth cone after encountering the beads was 
determined using a series of time-lapse images.  Angles of axon direction change were 
measured using ImageJ (Wayne Rasband, NIH) before and after the growth cone encountered 
the beads.  An angle above zero indicates that the growth cones moved away from the beads, 
and an angle below zero indicates that they moved toward the beads.  The data were evalu-
ated using ANOVA, followed by Bonferroni’s test.   
 Since the growth cones turning angles against CSE-PE bead seemed to be distributed in 
a bimodal manner at 20° (Fig. 5C), behaviors of growth cones were categorized into 3 types as 
retraction (A), turning away by more than 20° (B) and turning by less than 20° (C).  The per-
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centages shown (A+B)/(A+B+C) as "growth cones moving away remarkably" were evaluated 
using the chi-square test.   
 All the experimental procedures were approved by the Committee for Animal Care and 
Use of the University of Tsukuba.   
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Figure legends 
Figure 1 
Schematic representation of CS units, structures, and related enzymes.  CSs are 
unbranched polysaccharides composed of repeating units of disaccharide (glucuronic acid 
and N-acetylgalactosamine) that are classified into A-, C-, D-, and E-units depending on 
sulfation sites; structural diversity of CSs results from combinations of these units.  A-unit of 
CS [GlcAβ1-3GalNAc(4-O-sulfate)] is synthesized by chondroitin 4-O-sulfotransferases.  C-
unit of CS [GlcAβ1-3GalNAc(6-O-sulfate)] is synthesized by chondroitin 6-O-
sulfotransferases.  D-unit of CS [GlcA(2-O-sulfate)β1-3GalNAc(6-O-sulfate)] is synthesized 
by sequential modification with chondroitin 6-O-sulfotransferases and uronyl 2-O-
sulfotransferase.  E-unit of CS [GlcAβ1-3GalNAc(4,6-O-disulfate)] is synthesized by 
sequential modification with chondroitin 4-O-sulfotransferases and N-acetylgalactosamine 4-
sulfate 6-O-sulfotransferase.   
 
Figure 2 
Beads coated with lipid-derivatized CS.  The structural diversity of CS is demonstrated using 
fluorescence-activated sorter analysis with monoclonal anti-CS antibodies.  (A) Schematic 
representation of lipid-derivatized CS consisting of a CS chain and a 
phosphatidylethanolamine (PE portion).  Sulfation occurs on the R2 site in the A unit of CS 
(GlcA-GalNAc[4S]), R3 site in C unit (GlcA-GalNAc[6S]), R1 and R3 sites in D unit (GlcA[2S]-
GalNAc[6S]), and R2 and R3 sites in E unit (GlcA-GalNAc[4S,6S]).  The cleavage sites of 
chondroitinase ABC (asterisk) and phospholipase D (sharp) are indicated.  (B) 
Immunoreactivity against anti-CS monoclonal antibody (CS-56) is shown for CSD-PE beads 
not treated with any enzyme (red), those treated with chondroitinase ABC (blue), and those 
treated with phospholipase D (green).  (C) Immunoreactivity of anti-CS monoclonal 
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antibodies with different specificities (MO-225: left, CS-56: middle, 2H6: right) shows that 
different preparations of CS exhibit structural diversity (uncoated: light blue, CSA-PE: black, 
CSC-PE: dark blue, CSD-PE: green, CSE-PE: purple).  (D) Scatter plot between growth 
cone's behaviors and contact angle of a growth cone to a CS-PE bead.  Contact angles 
"zero" and "90°" indicate that "growth cone encountering in the front of the bead" and "growth 
cone touching the bead laterally at a right angle", respectively. Horizontal dotted lines 
indicate mean contact angles of growth cone to the beads.  CS, chondroitin sulfate; CS-PE, 
lipid-derivatized chondroitin sulfate 
 
Figure 3  
Behaviors of retinal growth cones.  Retraction of retinal growth cone encountering a CSE-
PE bead (A) and turning of retinal growth cones encountering a CSC-PE bead (B), CSE-PE 
bead (C), and CSE-PE bead treated with chondroitinase ABC (D) are shown in a series of 
time-lapse images.  Their turning angles are measured in superpositions of time-lapse 
images: 6.7° for the CSC-PE bead, 20.2° for the CSE-PE bead, and 2.6° for the CSE-PE 
bead treated with chondroitinase ABC.  Scale bars, 6 µm.   
CS, chondroitin sulfate; CS-PE, lipid-derivatized chondroitin sulfate 
 
Figure 4 
Retinal growth cones retract from CSE-PE beads.  (A) Percentages of the retraction are 
shown on beads without any coating (-), beads coated with CSA-PE, CSC-PE, CSD-PE, 
CSE-PE, and CSE-PE treated with chondroitinase ABC.  Asterisk (*) and double asterisk 
(**) indicate significant differences in the percentages of the retraction (chi-square test, *: p < 
0.05 and **: p < 0.01).  (B) The growth cones retract more slowly on CSE-PE beads than 
the other beads.  CSE-PE beads halt the growth cones for a significantly longer period 
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during the retraction.  Double asterisk (**) indicates significant difference between CSE-PE 
and the other beads in contact and halt during the retraction (Mann-Whitney U test, p < 0.01).   
CS, chondroitin sulfate; CS-PE, lipid-derivatized chondroitin sulfate 
 
Figure 5 
Retinal growth cones halt on and turn away from CSE-PE beads.  (A) Halt time of retinal 
growth cones is plotted against beads without any coating (-), beads coated with CSA-PE, 
CSC-PE, CSD-PE, CSE-PE, and CSE-PE treated with chondroitinase ABC.  (B) Mean halt 
time and their standard errors are shown.  Asterisk (*) and double asterisk (**) indicate a 
significant difference in the halt of CSE-PE beads against (-) beads (*: p < 0.05), CSA-PE 
beads (**: p < 0.01), and CSD-PE beads (*: p < 0.05) (ANOVA followed by Bonferroni’s test).  
(C) Turning angles of retinal growth cones are plotted against beads without any coating (-), 
beads coated with CSA-PE, CSC-PE, CSD-PE, CSE-PE, and CSE-PE treated with 
chondroitinase ABC.  An angle above zero indicates that the growth cones turn away from 
the beads, and an angle below zero indicates that they turn toward the beads.  (D) Mean 
turning angles and their standard errors are shown.  Double asterisk (**) indicates significant 
differences between the turning angle of CSE-PE and those of other groups (ANOVA 
followed by Bonferroni’s test, p < 0.01).  
CS, chondroitin sulfate; CS-PE, lipid-derivatized chondroitin sulfate 
  
Figure 6 
Percentages of "the retracted growth cones" plus "growth cones of turning angle more than 
20°" are evaluated.  Triple asterisk (***) indicates significant differences between CSE-PE 
beads and the other beads (chi-square test, p < 0.0001).   
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